With Signals Notebook, AstraZeneca Increases Productivity for Developing Complex Therapeutics
With Signals Notebook, AstraZeneca Increases Productivity for Developing Complex Therapeutics
5 PagesAstraZeneca, a global science-led pharmaceutical company, faced R&D bottlenecks from its legacy electronic lab notebook, which was slow, clunky, and unsupported collaboration or complex chemistry-biology data for new drug modalities. Revvity Signals Notebook transformed this by providing a fast, intuitive platform that captures large volumes of multimodal data, enables seamless real-time collaboration, and facilitates data reuse across experiments. Scientists now share insights directly without external tools, accelerating breakthrough discoveries, streamlining workflows, and empowering the organization to deliver life-changing medicines more efficiently.
